MERS-CoV vaccine successfully tested in monkeys and camels
20 August 2015 | By Victoria White
Scientists have reported that an experimental vaccine given six weeks before exposure to MERS-CoV fully protects rhesus macaques from disease...
List view / Grid view
News
New high-throughput screening method could speed drug discovery
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
Roche to acquire Kapa Biosystems
19 August 2015 | By Victoria White
Roche has signed a definitive agreement to acquire Kapa Biosystems, strengthening Roche's next-generation sequencing product offerings...
AmpliPhi Biosciences receives approval for listing on NYSE MKT
19 August 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that its shares of common stock have been approved for listing on the NYSE MKT...
Cancer Research UK funding preclinical study of Imprime PGG
18 August 2015 | By Victoria White
Cancer Research UK will fund preclinical research evaluating the efficacy of Imprime PGG in combination with monoclonal antibody (MAb) therapies...
European Antibody Congress 2015 comes to Basel
18 August 2015 | By The European Antibody Congress
The European Antibody Congress takes place 9-11 November 2015 at the Congress Centre, Basel...
CLR01 targets HIV and prevents semen from promoting infection
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
Genetic test could improve myeloma treatment
18 August 2015 | By Victoria White
Testing for genetic risk factors could improve treatment for myeloma patients by identifying those at risk of developing more aggressive disease...
Bionic liver organs explain toxicity of paracetamol
17 August 2015 | By Victoria White
Scientists have created a liver-on-chip device mimicking human physiology, leading to the discovery of a new mechanism of paracetamol toxicity...
Promising new target for cognitive disorders identified
17 August 2015 | By Victoria White
Genetically altered mice could form the basis for research into new treatments for cognitive disorders such as Alzheimer’s disease and schizophrenia...
Researchers discover adhesive strategy of H. pylori
17 August 2015 | By Victoria White
Researchers from have identified the molecular mechanism that an adhesion protein of H. pylori uses to attach to stomach ulcers...
Epstein-Barr virus vaccine induces potent neutralising antibodies
17 August 2015 | By Victoria White
Researchers have developed an experimental, nanoparticle-based vaccine against Epstein-Barr virus that can induce potent neutralising antibodies in animals...
Cells regenerate liver without cancer risk
17 August 2015 | By Victoria White
Researchers supported by the NIH have discovered a type of cell, known as hybrid hepatocytes, essential to regeneration of the liver...
AmpliPhi Biosciences announce financial results Q2 2015
14 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Biotechnology company, AmpliPhi Biosciences Corporation, released financial results for the second quarter 2015 and operational highlights. AmpliPhi, one of the leaders in the development of bacteriophage-based antibacterial therapies to treat antibiotic-resistant infections, has reported strong overall performance in overall liquidity and balance sheet strength thanks to a $13 million investment…
Research suggests ion channel blocking drugs could be used in cancer therapy
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
